Skip to main content
. Author manuscript; available in PMC: 2024 Aug 25.
Published in final edited form as: Pediatr Res. 2024 Jan 8;96(2):402–408. doi: 10.1038/s41390-023-02970-y

Table 2.

Associations between growth, body composition and IGF-1/IGFBP-3 Levels in VLBW Infants.

Measure Variable IGF-1 (n = 44 DOL 7, n = 39 35 wk PMA) IGFBP-3 (n = 45 DOL 7, n = 43 35 wk PMA)
Time β (95% CI) p-value Time β (95% CI) p-value
Growth Birth weight, z-score
DOL 7 1.99 (−0.92, 4.91) 0.177 DOL 7 0.05 (−0.04, 0.14) 0.272
35 weeks PMA 0.39 (−4.33, 5.11) 0.869 35 weeks PMA 0.07 (−0.04, 0.19) 0.215
Birth length, z-score
DOL 7 1.42 (−0.85, 3.7) 0.215 DOL 7 0.04 (−0.03, 0.11) 0.230
35 weeks PMA 2.81 (−0.59, 6.21) 0.103 35 weeks PMA 0.11 (0.02, 0.2) 0.014
Weight at discharge, z-score
DOL 7 0.3 (0, 0.06) 0.086 DOL 7 0.74 (−0.77, 2.25) 0.326
35 weeks PMA 0.01 (−0.02, 0.03) 0.433 35 weeks PMA 0.75 (−0.13, 1.62) 0.091
Length at discharge, z-score
DOL 7 0.03 (−0.01, 0.06) 0.106 DOL 7 1.41 (−0.16, 2.99) 0.078
35 weeks PMA 0.01 (−0.01, 0.04) 0.271 35 weeks PMA 1.1 (0.17, 2.03) 0.022
OFC at discharge, z-score
DOL 7 0.02 (−0.01, 0.05) 0.231 DOL 7 0.69 (−0.81, 2.2) 0.358
35 weeks PMA 0 (−0.03, 0.02) 0.755 35 weeks PMA −0.02 (−0.96, 0.91) 0.959
Body Composition Fat mass at discharge, z-score
DOL 7 0.07 (0, 0.15) 0.053 DOL 7 0.59 (−2.74, 3.92) 0.722
35 weeks PMA 0.03 (−0.03, 0.08) 0.329 35 weeks PMA 0.87 (−1, 2.75) 0.352
Fat free mass at discharge, z-score
DOL 7 0.03 (−0.02, 0.07) 0.200 DOL 7 1.44 (−0.45, 3.32) 0.131
35 weeks PMA 0.01 (−0.02, 0.04) 0.451 35 weeks PMA 1 (−0.07, 2.08) 0.066
Percent body fat at discharge, %
DOL 7 0.03 (−0.04, 0.1) 0.464 DOL 7 0.3 (−2.75, 3.34) 0.844
35 weeks PMA 0.02 (−0.03, 0.06) 0.494 35 weeks PMA 0.35 (−1.34, 2.04) 0.677
IGF-1/IGFBP-3 Levels Early IGF-1
DOL 7 0.01 (0.01, 0.02) <0.001
35 weeks PMA 0.1 (−0.36, 0.55) 0.676 35 weeks PMA 0.01 (0, 0.02) 0.126
Early IGFBP-3
DOL 7 0.01 (0.01, 0.02) <0.001
35 weeks PMA 19.07 (7.73, 30.41) 0.001 35 weeks PMA 0.56 (0.28, 0.84) <0.001

All variables were studied separately and adjusted for birth gestational age, PMA at DOL 7/35 weeks, sex, and study arm (intervention vs control).

DOL Day of life, PMA Postmenstrual age.